Usefulness of CEA concentration measurement and classic colonoscopy in follow-up after radical treatment of colorectal cancer

Pol Przegl Chir. 2011 Jun;83(6):310-8. doi: 10.2478/v10035-011-0048-y.

Abstract

There is always a certain rate of recurrence after radical treatment for cancer and to get on it an early detection of disease set back is crucial.

Material and methods: Medical data of patients operated on for primarily detected colorectal cancer in years 1993-2002 was retrospectively reviewed. Usefulness of follow-up means such as physical examination, or CEA and endoscopic surveillance was analyzed. All mentioned above were applied to scheduled follow-up (in 3, 6 and 12 month intervals following an operation and annually after that by the year 5).

Results: Complete and reliable data was obtained from 340 out of 502 follow-up intended subjects (67.7%). Elevated CEA was the most frequent predictor of recurrence within non-symptomatic subjects meeting follow-up appointments (60%). The cancer set back diagnosed by means of either physical or endoscopic examinations was the case only in one out of five patients (20.75% and 18.87% respectively). Clinical onset of recurrence making patients meet an unscheduled appointment was found increasing relative risk of nothing-but-palliative option either for them with local set back, or meta-static spread. Relative risk of onset of meta-chronous colonic cancer was significantly higher in patients being affected by synchronous advanced adenoma at time of surgery compared to those with one-fold changes.

Conclusions: CEA scheduled follow-up after treatment for colorectal cancer CRC seems adequate to provide a good outcome of treatment for recurrent tumors. CRC patients presenting with synchronous advanced adenomas at time of surgery are probably to be under more intensive endoscopic surveillance.

Publication types

  • Comparative Study

MeSH terms

  • Carcinoembryonic Antigen / blood*
  • Colonoscopy / methods
  • Colorectal Neoplasms / blood*
  • Colorectal Neoplasms / surgery*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Neoplasm Recurrence, Local / blood*
  • Retrospective Studies

Substances

  • Carcinoembryonic Antigen